These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37025259)

  • 61. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
    Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
    Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic significance of serum carcinoembryonic antigen and squamous cell carcinoma antigen in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
    Hu J; Kuang P; Chen D; Chen Y; Wen Z
    Transl Cancer Res; 2020 Apr; 9(4):2460-2471. PubMed ID: 35117605
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH; Yu M; Jeong S; Lee JH
    Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma.
    Liu Y; Shi L; Chen K; Ye W
    Curr Probl Cancer; 2022 Dec; 46(6):100899. PubMed ID: 36270166
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
    Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy.
    Zhang X; Zhang Q; Guo J; Zhao J; Xie L; Zhang J; An J; Yu X; Zhao X
    Eur J Radiol; 2022 May; 150():110272. PubMed ID: 35334244
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage.
    Balaya V; Guani B; Magaud L; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F; On Behalf Of The Senticol Group
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260758
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Husain ZA; Chen T; Corso CD; Wang Z; Park H; Judson B; Yarbrough W; Deshpande H; Mehra S; Kuo P; Decker RH; Burtness BA
    JAMA Oncol; 2017 Mar; 3(3):358-365. PubMed ID: 27737449
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer.
    An Q; Liu W; Yang Y; Yang B
    BMC Cancer; 2020 Jul; 20(1):691. PubMed ID: 32711484
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.
    Yen TC; See LC; Lai CH; Tsai CS; Chao A; Hsueh S; Hong JH; Chang TC; Ng KK
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):493-501. PubMed ID: 17955238
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospective Analysis of Squamous Cell Carcinoma Antigen-1 and -2 for Diagnosing Sinonasal Inverted Papilloma.
    Hirakawa H; Ikegami T; Toyama M; Ooshiro Y; Higa T; Kinjyo H; Kondo S; Kise N; Yamashita Y; Suzuki M
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731250
    [No Abstract]   [Full Text] [Related]  

  • 73. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
    Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
    Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.
    Zhang J; Shao C; Zhou Q; Zhu Y; Zhu J; Tu C
    Mol Clin Oncol; 2015 Sep; 3(5):1165-1171. PubMed ID: 26623071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
    Bell EH; Pugh SL; McElroy JP; Gilbert MR; Mehta M; Klimowicz AC; Magliocco A; Bredel M; Robe P; Grosu AL; Stupp R; Curran W; Becker AP; Salavaggione AL; Barnholtz-Sloan JS; Aldape K; Blumenthal DT; Brown PD; Glass J; Souhami L; Lee RJ; Brachman D; Flickinger J; Won M; Chakravarti A
    JAMA Oncol; 2017 Jun; 3(6):784-792. PubMed ID: 28097324
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.
    Hui EP; Li WF; Ma BB; Lam WKJ; Chan KCA; Mo F; Ai QYH; King AD; Wong CH; Guo R; Poon DMC; Tong M; Li L; Lau TKH; Wong KCW; Lam DCM; Lo YMD; Ma J; Chan ATC
    Ann Oncol; 2020 Jun; 31(6):769-779. PubMed ID: 32217076
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
    Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel 2-deoxy-2-fluorodeoxyglucose (
    Liu S; Feng Z; Zhang J; Ge H; Wu X; Song S
    Quant Imaging Med Surg; 2021 Jan; 11(1):240-248. PubMed ID: 33392025
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.